IP Library Granted Patent US 10,232,028
Granted Patent B2
US 10,232,028 · App. 14/898,091 · Granted Mar 19, 2019

Compounds and methods for affecting cytokines

Inventor: Andrew Dahl (Bloomfield Hills, MI)
Assignee: ZIVO BIOSCIENCE, INC.
A61K39/092A61K35/74A61K35/744A61K36/02A61K36/06A61K36/10A61K39/0258A61K39/09
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,232,028
App. No.
14/898,091
Granted
Mar 19, 2019
Kind
B2
Abstract

The present invention discloses isolates and fractions from a phyto-percolate and methods for affecting various cytokines by administering an effective amount of one or more of said isolates or fractions to an animal. In various exemplary embodiments, the isolates are useful for the treatment of bovine, canine and swine infection or inflammation, including bovine mastitis, by regulation of TNF-a, lactoferrin, IFN-γ, IL-I β, serum amyloid-A (SAA), IL-6 and/or β-defensin associated with infection or an immune response generally.

Claims (14)

1. A method of treating mastitis in a cow, said method comprising administering to said cow a therapeutically effective amount of one or more of (a) a phyto-percolate isolate produced by culturing microorganisms of ATCC Deposit No. PTA-5863, wherein said isolate source is ABC Composite Lot #8 PAZ with a LC retention time of 3.29 minutes; 3.64 minutes, and MS (M+H; Daltons) 453; 679; (b) a phyto-percolate isolate produced by culturing microorganisms of ATCC Deposit No. PTA-5863, wherein said isolate source is Gelding Reserve PAZ with a LC retention time of 3.29 minutes; 3.64 minutes, and MS (M+H; Daltons) 453; 679; (c) a phyto-percolate isolate produced by culturing microorganisms of ATCC Deposit No. PTA-5863, wherein said isolate source is Gelding Reserve with a LC retention time of 3.29 minutes; 3.64 minutes, and MS (M+H; Daltons) 453; 679; (d) a phyto-percolate isolate produced by culturing microorganisms of ATCC Deposit No. PTA-5863, wherein said isolate source is Gelding reserve tank sample with a LC retention time of 3.29 minutes; 3.64 minutes, and MS (M+H; Daltons) 453; 679; and (e) a phyto-percolate isolate produced by culturing microorganisms of ATCC Deposit No. PTA-5863, wherein said isolate source is dilute ABC Composite Lot #8 PAZ with a LC retention time of 0.58 minutes; 2.43 minutes; 2.93 minutes; 3.14 minutes; 3.50 minutes; 3.78 minutes; 4.07 minutes; 4.35 minutes; 4.92 minutes; 5.14 minutes; 5.57 minutes; 6.99 minutes; 7.35 minutes; 7.63 minutes.

2. The method of claim 1 , wherein the one or more isolates produced by culturing microorganisms of ATCC Deposit No. PTA-5863 up-regulate at least one anti-inflammatory cytokine in bovine mammary epithelial cells, and/or down-regulate at least one pro-inflammatory cytokine in bovine mammary epithelial cells.

3. The method of claim 2 , wherein each of said cytokines is selected from the group consisting of TNF-α, lactoferrin, IFN-γ, IL-1β, serum amyloid-A (SAA), IL-6 and β-defensin.

4. A method of modulating an immune response in bovine, swine or canine, said method comprising the step of administering to said bovine, swine or canine an effective amount of one or more of (a) a phyto-percolate isolate produced by culturing microorganisms of ATCC Deposit No. PTA-5863, wherein said isolate source is ABC Composite Lot #8 PAZ with a LC retention time of 3.29 minutes; 3.64 minutes, and MS (M+H; Daltons) 453; 679; (b) a phyto-percolate isolate produced by culturing microorganisms of ATCC Deposit No. PTA-5863, wherein said isolate source is Gelding Reserve PAZ with a LC retention time of 3.29 minutes; 3.64 minutes, and MS (M+H; Daltons) 453; 679; (c) a phyto-percolate isolate produced by culturing microorganisms of ATCC Deposit No. PTA-5863, wherein said isolate source is Gelding Reserve with a LC retention time of 3.29 minutes; 3.64 minutes, and MS (M+H; Daltons) 453; 679; (d) a phyto-percolate isolate produced by culturing microorganisms of ATCC Deposit No. PTA-5863, wherein said isolate source is Gelding reserve tank sample with a LC retention time of 3.29 minutes; 3.64 minutes, and MS (M+H; Daltons) 453; 679; and (e) a phyto-percolate isolate produced by culturing microorganisms of ATCC Deposit No. PTA-5863, wherein said isolate source is dilute ABC Composite Lot #8 PAZ with a LC retention time of 0.58 minutes; 2.43 minutes; 2.93 minutes; 3.14 minutes; 3.50 minutes; 3.78 minutes; 4.07 minutes; 4.35 minutes; 4.92 minutes; 5.14 minutes; 5.57 minutes; 6.99 minutes; 7.35 minutes; 7.63 minutes, wherein said immune response is characteristic of bovine mastitis, bovine respiratory disease complex, transition cow syndrome, canine osteoarthritis, canine skeletal-muscular overexertion, or porcine reproductive and respiratory syndrome virus immune disorder.

5. The method of claim 4 , wherein said immune response is triggered by the presence of at least one of Staphylococcus aureus, Streptococcus uberis , and Escherichia coli.

6. The method of claim 4 , wherein the one or more isolates produced by culturing microorganisms of ATCC Deposit No. PTA-5863 up-regulate at least one anti-inflammatory cytokine, and/or down-regulate at least one pro-inflammatory cytokine involved in said immune response.

7. The method of claim 6 , wherein each of said cytokines is selected from the group consisting of TNF-α, lactoferrin, IFN-γ, IL-1β, serum amyloid-A (SAA), IL-6 and β-defensin.

8. A method of promoting an antimicrobial response at a site of infection in an animal, said method comprising the step of administering to said animal an effective amount of one or more of (a) a phyto-percolate isolate produced by culturing microorganisms of ATCC Deposit No. PTA-5863, wherein said isolate source is ABC Composite Lot #8 PAZ with a LC retention time of 3.29 minutes; 3.64 minutes, and MS (M+H; Daltons) 453; 679; (b) a phyto-percolate isolate produced by culturing microorganisms of ATCC Deposit No. PTA-5863, wherein said isolate source is Gelding Reserve PAZ with a LC retention time of 3.29 minutes; 3.64 minutes, and MS (M+H; Daltons) 453; 679; (c) a phyto-percolate isolate produced by culturing microorganisms of ATCC Deposit No. PTA-5863, wherein said isolate source is Gelding Reserve with a LC retention time of 3.29 minutes; 3.64 minutes, and MS (M+H; Daltons) 453; 679; (d) a phyto-percolate isolate produced by culturing microorganisms of ATCC Deposit No. PTA-5863, wherein said isolate source is Gelding reserve tank sample with a LC retention time of 3.29 minutes; 3.64 minutes, and MS (M+H; Daltons) 453; 679; and (e) a phyto-percolate isolate produced by culturing microorganisms of ATCC Deposit No. PTA-5863, wherein said isolate source is dilute ABC Composite Lot #8 PAZ with a LC retention time of 0.58 minutes; 2.43 minutes; 2.93 minutes; 3.14 minutes; 3.50 minutes; 3.78 minutes; 4.07 minutes; 4.35 minutes; 4.92 minutes; 5.14 minutes; 5.57 minutes; 6.99 minutes; 7.35 minutes; 7.63 minutes.

9. The method of claim 8 , wherein said animal is a cow.

10. The method of claim 9 , wherein said site of infection is mammary tissue.

11. The method of claim 8 , wherein said site of infection comprises the presence of Staphylococcus, Streptococcus, Escherichia , or Mycoplasma pathogens.

12. The method of claim 8 , wherein the one or more isolates produced by culturing microorganisms of ATCC Deposit No. PTA-5863 up-regulate at least one anti-inflammatory cytokine, and/or down-regulate at least one pro-inflammatory cytokine within cells at said site of infection.

13. The method of claim 12 , wherein each of said cytokines is selected from the group consisting of TNF-α, lactoferrin, IFN-γ, IL-1β, serum amyloid-A (SAA), IL-6 and β-defensin.

14. The method of claim 12 , wherein said animal is a cow, said cells comprise bovine mammary epithelial cells, and said site of infection is bovine mammary tissue.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 24, 2018
From: DAHL, ANDREW A.
To: ZIVO BIOSCIENCE, INC.
Reel/Frame 047303/0562 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 17, 2018
From: DAHL, ANDREW
To: HEALTH ENHANCEMENT PRODUCTS, INC.
Reel/Frame 047204/0751 →
CHANGE OF NAME Recorded Oct 17, 2018
From: HEALTH ENHANCEMENT PRODUCTS, INC.
To: ZIVO BIOSCIENCE, INC.
Reel/Frame 047871/0812 →
Continuity (2)
Continuation 61834842 · Jun 13, 2013
Related Publication 20160120970A1 · May 5, 2016